[1]
A. . CHRISTOPHER and M. Sweet, “ASSESSING ANTICOAGULATION SAFETY AND EFFICACY IN ANTIPHOSPHOLIPID SYNDROME PATIENTS MONITORED BY FACTOR II ACTIVITY ASSAY”, Asian J Pharm Clin Res, vol. 10, no. 3, pp. 398–401, Mar. 2017.